← Leaderboards
Thelma Therezinha Goncalez
Vitalant
$760,595
Attributed
$760,595
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $353.7K · FY2011–14$500K$375K$250K$125K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$760,595 · 1
By mechanism
R01$760,595 · 1
Top collaborators
No co-investigators on record.
Most similar at Vitalant
Same institution · by research overlap
- Graham Simmons$8,136,951
- Shibani Pati$3,927,694
- Evan Martin Bloch$1,333,371
- Brian Custer$12,613,797
- Rachael Peretz Jackman$4,091,830
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesAntiretroviral TherapyBehaviorBehavioralBehavior ChangeBiological MarkersBloodBlood BanksBlood DonationsBlood DonorBlood ProductBlood TransfusionBlood VolumeBrazilCaringChagas DiseaseClientCommunitiesCounselingCountryDeveloping CountriesDiagnosisDisclosureAltruism
Grant awards (4)
Improving blood safety and HIV testing in Brazil: a randomized controlled trial$81,564
R01 · FY2014 · HL · contact PI
Improving blood safety and HIV testing in Brazil: a randomized controlled trial$133,040
R01 · FY2013 · HL · contact PI
Improving blood safety and HIV testing in Brazil: a randomized controlled trial$353,660
R01 · FY2012 · HL · contact PI
Improving blood safety and HIV testing in Brazil: a randomized controlled trial$192,331
R01 · FY2011 · HL · contact PI